These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 26138651)

  • 1. Concurrent Obesity, Diabetes, and Steatosis Increase Risk of Advanced Fibrosis Among HCV Patients: A Systematic Review.
    Dyal HK; Aguilar M; Bhuket T; Liu B; Holt EW; Torres S; Cheung R; Wong RJ
    Dig Dis Sci; 2015 Sep; 60(9):2813-24. PubMed ID: 26138651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes Mellitus Increases Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Virus Patients: A Systematic Review.
    Dyal HK; Aguilar M; Bartos G; Holt EW; Bhuket T; Liu B; Cheung R; Wong RJ
    Dig Dis Sci; 2016 Feb; 61(2):636-45. PubMed ID: 26703125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity and non-alcoholic fatty liver disease in chronic hepatitis C.
    Younossi ZM; McCullough AJ; Ong JP; Barnes DS; Post A; Tavill A; Bringman D; Martin LM; Assmann J; Gramlich T; Mullen KD; O'Shea R; Carey WD; Ferguson R
    J Clin Gastroenterol; 2004 Sep; 38(8):705-9. PubMed ID: 15319656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Data mining of routine laboratory tests can predict liver disease progression in Egyptian diabetic patients with hepatitis C virus (G4) infection: a cohort study of 71 806 patients.
    Saad Y; Awad A; Alakel W; Doss W; Awad T; Mabrouk M
    Eur J Gastroenterol Hepatol; 2018 Feb; 30(2):201-206. PubMed ID: 29099423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steatohepatitis is associated with diabetes and fibrosis in genotype 1b HCV-related chronic liver disease.
    Masarone M; La Mura V; Bruno S; Gaeta GB; Vecchione R; Carrino F; Moschella F; Torella R; Persico M
    J Viral Hepat; 2007 Oct; 14(10):714-20. PubMed ID: 17875006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus, and alcohol.
    Monto A; Alonzo J; Watson JJ; Grunfeld C; Wright TL
    Hepatology; 2002 Sep; 36(3):729-36. PubMed ID: 12198667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Risk of Cardiovascular Disease, Diabetes, Liver-Related Outcomes, and Death Over 10 Years in HIV/HCV-Coinfected Patients With and Without Steatosis.
    Down C; Mehta N; Marks K
    AIDS Res Hum Retroviruses; 2016 Sep; 32(9):868-71. PubMed ID: 27206965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of obesity and diabetes on waitlist survival, probability of liver transplantation and post-transplant survival among chronic hepatitis C virus patients.
    Aguilar M; Liu B; Holt EW; Bhuket T; Wong RJ
    Liver Int; 2016 Aug; 36(8):1167-75. PubMed ID: 26858016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of the prevalence and grade of steatosis in patients with chronic hepatitis C with the host and viral factors.
    Liakina V; Speiciené D; Irnius A; Semuchiniené T; Valantinas J
    Acta Gastroenterol Belg; 2007; 70(3):260-6. PubMed ID: 18074734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fat, diabetes, and liver injury in chronic hepatitis C.
    Ratziu V; Trabut JB; Poynard T
    Curr Gastroenterol Rep; 2004 Feb; 6(1):22-9. PubMed ID: 14720450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryoglobulinemia is associated with steatosis and fibrosis in chronic hepatitis C.
    Saadoun D; Asselah T; Resche-Rigon M; Charlotte F; Bedossa P; Valla D; Piette JC; Marcellin P; Cacoub P
    Hepatology; 2006 Jun; 43(6):1337-45. PubMed ID: 16729318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic fatty liver disease and hepatic cirrhosis: Comparison with viral hepatitis-associated steatosis.
    Haga Y; Kanda T; Sasaki R; Nakamura M; Nakamoto S; Yokosuka O
    World J Gastroenterol; 2015 Dec; 21(46):12989-95. PubMed ID: 26675364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical implications of hepatic steatosis in patients with chronic hepatitis C: a multicenter study of U.S. veterans.
    Hu KQ; Currie SL; Shen H; Cheung RC; Ho SB; Bini EJ; McCracken JD; Morgan T; Bräu N; Schmidt WN; Jeffers L; Wright TL;
    Dig Dis Sci; 2007 Feb; 52(2):570-8. PubMed ID: 17226072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic steatosis in chronic hepatitis C virus infection: prevalence and clinical correlation.
    Hwang SJ; Luo JC; Chu CW; Lai CR; Lu CL; Tsay SH; Wu JC; Chang FY; Lee SD
    J Gastroenterol Hepatol; 2001 Feb; 16(2):190-5. PubMed ID: 11207900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data.
    Leandro G; Mangia A; Hui J; Fabris P; Rubbia-Brandt L; Colloredo G; Adinolfi LE; Asselah T; Jonsson JR; Smedile A; Terrault N; Pazienza V; Giordani MT; Giostra E; Sonzogni A; Ruggiero G; Marcellin P; Powell EE; George J; Negro F;
    Gastroenterology; 2006 May; 130(6):1636-42. PubMed ID: 16697727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steatosis in chronic hepatitis C: relationship to the virus and host risk factors.
    Matos CA; Perez RM; Pacheco MS; Figueiredo-Mendes CG; Lopes-Neto E; Oliveira EB; Lanzoni VP; Silva AE; Ferraz ML
    J Gastroenterol Hepatol; 2006 Aug; 21(8):1236-9. PubMed ID: 16872303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of human immunodeficiency virus infection on the prevalence and severity of steatosis in patients with chronic hepatitis C virus infection.
    Gaslightwala I; Bini EJ
    J Hepatol; 2006 Jun; 44(6):1026-32. PubMed ID: 16618518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes mellitus, metabolic syndrome and obesity are not significant risk factors for hepatocellular carcinoma in an HBV- and HCV-endemic area of Southern Taiwan.
    Chen CT; Chen JY; Wang JH; Chang KC; Tseng PL; Kee KM; Chen PF; Tsai LS; Chen SC; Lin SC; Lu SN
    Kaohsiung J Med Sci; 2013 Aug; 29(8):451-9. PubMed ID: 23906236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with the progression of fibrosis on liver biopsy in Alaska Native and American Indian persons with chronic hepatitis C.
    Livingston SE; Deubner H; Bruden DL; McMahon BJ; Homan CE; Townshend-Bulson LJ; Bruce MG; Hennessy TW; Williams JL; Gretch DR
    Can J Gastroenterol; 2010 Jul; 24(7):445-51. PubMed ID: 20652161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity.
    Adinolfi LE; Gambardella M; Andreana A; Tripodi MF; Utili R; Ruggiero G
    Hepatology; 2001 Jun; 33(6):1358-64. PubMed ID: 11391523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.